Declining childhood and adolescent cancer mortality: Great progress but still much to be done

Declining childhood and adolescent cancer mortality

(2014) Malcolm A. Smith et al.   CANCER

Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors

(2014) J. F. Shern et al.   Cancer Discovery

Towards reducing inequalities: European Standards of Care for Children with Cancer

(2013) Jerzy R. Kowalczyk et al.   EUROPEAN JOURNAL OF CANCER

Need for change in implementation of paediatric regulation

(2013) Gilles Vassal et al.   LANCET ONCOLOGY

New drugs for children and adolescents with cancer: the need for novel development pathways

(2013) Gilles Vassal et al.   LANCET ONCOLOGY

Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries

(2013) Kathy Pritchard-Jones et al.   LANCET ONCOLOGY

New policies to address the global burden of childhood cancers

(2013) Richard Sullivan et al.   LANCET ONCOLOGY

Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study

(2013) Gemma Gatta et al.   LANCET ONCOLOGY

The genetic landscape of high-risk neuroblastoma

(2013) Trevor J Pugh et al.   NATURE GENETICS

Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas

(2013)   NATURE GENETICS

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

(2013) Stephan A. Grupp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Teenagers and young adults with cancer need better access to clinical trials

(2013) Z. Kmietowicz   BMJ-British Medical Journal

Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials

(2012) C. A. Stiller et al.   ANNALS OF ONCOLOGY

An international strategy to determine the role of high dose therapy in recurrent Wilms’ tumour

(2012) Tam C. Ha et al.   EUROPEAN JOURNAL OF CANCER

Children, Adolescents, and Young Adults With Leukemia: The Empty Half of the Glass Is Growing

(2012) Archie Bleyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Dissecting the genomic complexity underlying medulloblastoma

(2012) David T. W. Jones et al.   NATURE

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

(2012) Jeremy Schwartzentruber et al.   NATURE

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

(2012) Gang Wu et al.   NATURE GENETICS

Medicines for pediatric oncology: can we overcome the failure to deliver?

(2012) Agnes Saint-Raymond et al.   Expert Review of Clinical Pharmacology

Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables

(2010) David W. Ellison et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

(2010) Catriona Parker et al.   LANCET

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recruitment of Adolescents and Young Adults to Cancer Clinical Trials—International Comparisons, Barriers, and Implications

(2010) Lorna A. Fern et al.   SEMINARS IN ONCOLOGY

Childhood cancer mortality in Europe, 1970–2007

(2009) Cristina Bosetti et al.   EUROPEAN JOURNAL OF CANCER